- Home
- SLGL vs OVID Comparison
SLGL vs OVID Comparison
Compare SLGL & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLGL | OVID |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.8M | 116.8M |
| IPO Year | 2018 | 2017 |
Fundamental Metrics
Financial Performance| Metric | SLGL | OVID |
|---|---|---|
| Price | $42.02 | $1.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $50.00 | $3.50 |
| AVG Volume (30 Days) | 15.1K | ★ 1.8M |
| Earning Date | 11-20-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $18,970,000.00 | $6,610,000.00 |
| Revenue This Year | $121.82 | $1,077.56 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 62.04 | ★ 945.89 |
| 52 Week Low | $4.02 | $0.24 |
| 52 Week High | $52.26 | $2.01 |
Technical Indicators
Market Signals| Indicator | SLGL | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 55.90 | 46.85 |
| Support Level | $39.26 | $1.26 |
| Resistance Level | $44.04 | $1.64 |
| Average True Range (ATR) | 3.07 | 0.13 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 66.20 | 37.26 |
Price Performance
Historical ComparisonAbout SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.